Factors associated with HPV and other self-reported STI coinfections among sexually active Brazilian young adults: cross-sectional nationwide study

Carregando...
Imagem de Miniatura
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMJ PUBLISHING GROUP
Autores
KOPS, Natalia Luiza
BESSEL, Marina
HORVATH, Jaqueline Driemeyer Correia
DOMINGUES, Carla
SOUZA, Flavia Moreno Alves de
BENZAKEN, Adele Schwartz
PEREIRA, Gerson Fernando Mendes
MARANHAO, Ana Goretti Kalume
Citação
BMJ OPEN, v.9, n.6, article ID e027438, 7p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives To analyse factors associated with genital human papillomavirus (HPV) and other self-reported sexually transmitted infection (STI) coinfections among women and men aged 16-25 years from Brazil. Design A cross-sectional, nationwide, multicentre study. Setting 119 primary healthcare centres between September 2016 and November 2017. Participants 6388 sexually active young adults were enrolled by trained health professionals. Primary outcome measure Genital HPV and other self-reported STI coinfections. Results Of 3512 participants with valid data for genital HPV and (STI)-positive status, 276 (9.60%, 95%61 7.82% to 11.36%) had HPV/STI coinfection. Among men, HPV/STI coinfection was more prevalent than HPV infection alone. Among HPV-positive participants, the percentage of subjects who reported having another STI was highest for gonorrhoea at 4.24% (95% CI 2.67% to 5.81%), followed by syphilis, herpes and HIV. Smoking, drug use and ever having a same-sex sexual experience were risk factors that were uniquely associated with HPV/STI coinfection compared with HPV infection alone. Conclusions The results identified a low prevalence of self-reported STIs, but in participants with at least one STI, the prevalence of HPV was high. These results reinforce the importance of implementing strategies to prevent risky behaviours among Brazilian young adults.
Palavras-chave
Referências
  1. Amorim AT, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2835-5
  2. Araujo ACL, 2012, INT J GYNECOL OBSTET, V117, P211, DOI 10.1016/j.ijgo.2011.12.024
  3. Associacao Brasileira de Empresas de Pesquisa, 2015, CRIT CLASS EC BRAS
  4. Ayres Andréia Rodrigues Gonçalves, 2010, Rev. Saúde Pública, V44, P963
  5. Badial RM, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009545
  6. Bastos Francisco Inácio, 2008, Rev. Saúde Pública, V42, P1, DOI 10.1590/S0034-89102008000800001
  7. Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244
  8. Brickman C, 2015, CURR HIV-AIDS REP, V12, P6, DOI 10.1007/s11904-014-0254-4
  9. Burchell AN, 2006, VACCINE, V24, P52, DOI 10.1016/j.vaccine.2006.05.031
  10. Castellsague X, 2002, VIRUS RES, V89, P191, DOI 10.1016/S0168-1702(02)00188-0
  11. Comar M, 2017, J MED VIROL, V89, P1654, DOI 10.1002/jmv.24811
  12. Dariotis JK, 2009, J ADOLESCENT HEALTH, V45, P187, DOI 10.1016/j.jadohealth.2008.12.024
  13. Dev D, 2006, JAIDS-J ACQ IMM DEF, V41, P527, DOI 10.1097/01.qai.0000186372.02925.4b
  14. Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813
  15. Global Adult Tobacco Survey Collaborative Group, 2011, TOB QUEST SURV SUBS
  16. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre), 2017, HUM PAP REL DIS WORL, V27
  17. INCA-Instituto Nacional de Cancer-Estimativa, EST 2018 INTR
  18. Instituto Brasileiro de Geografia e Estatistica-IBGE, 2010, CAR GER POP REL PESS, P1
  19. KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804
  20. Lin CQ, 2018, LANCET INFECT DIS, V18, P198, DOI [10.1016/S1473-3099(17)30653-9, 10.1016/s1473-3099(17)30653-9]
  21. Logie CH, 2018, AIDS BEHAV, V22, P1987, DOI 10.1007/s10461-017-1781-y
  22. Mbulawa ZZA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190166
  23. McQuillan Geraldine, 2017, NCHS Data Brief, P1
  24. Menezes LJ, 2018, SEX TRANSM INFECT, V94, P55, DOI 10.1136/sextrans-2016-053046
  25. Minkoff H., 2008, INFECT DIS OBSTET GY, V2008, P1, DOI 10.1155/2008/587082
  26. Ortiz AP, 2017, PAPILLOMAVIRUS RES, V4, P39, DOI 10.1016/j.pvr.2017.06.006
  27. Qian HZ, 2017, SEX TRANSM DIS, V44, P656, DOI 10.1097/OLQ.0000000000000672
  28. Schabath MB, 2012, CANCER EPIDEM BIOMAR, V21, P102, DOI 10.1158/1055-9965.EPI-11-0591
  29. Smith JS, 2002, JNCI-J NATL CANCER I, V94, P1604, DOI 10.1093/jnci/94.21.1604
  30. Tartaglia E, 2017, ONCOL LETT, V14, P7629, DOI 10.3892/ol.2017.7140
  31. Unemo M, 2017, LANCET INFECT DIS, V17, pE235, DOI [10.1016/S1473-3099(17)30310-9, 10.1016/s1473-3099(17)30310-9]
  32. Veldhuijzen NJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-333
  33. Wendland EM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021170
  34. WHO, 2016, GLOB HLTH SECT STRAT
  35. Xu L, 2018, J CLIN VIROL, V98, P37, DOI 10.1016/j.jcv.2017.12.001